In collaboration with colleagues across the country, Kristin Stegenga, RN, PhD, is studying the
symptoms that adolescents and young adults experience while undergoing stem
cell transplant (SCT).
SCT has proven to be a curative treatment for cancer and a
number of other blood and immune disorders. Although great strides have been
made in the management of complications associated with SCT, patients often
struggle with significant side effects of the treatment. This study, funded by the
Children’s Oncology Group, will build our knowledge base about the unique
experience of adolescents and young adults undergoing SCT and help us identify
ways to further improve the recovery process.
This research is part of Dr. Stegenga’s ongoing efforts to
better understand the impact that the diagnosis of cancer or blood disorders
have on the quality of life of adolescents and young adults, and to find ways
to mitigate the negative psychosocial effects of these diagnoses. The
Association of Pediatric Hematology/Oncology Nurses (APHON) recently recognized
Dr. Stegenga’s contributions and honored her with the Dr. Patricia Greene